Jiangsu Vcare Pharmatech Co., Ltd.
PrivateLast Round
Series C
Extension
Jun 2, 2026
Total Funding Raised
$224.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Jiangsu Vcare Pharmatech Co., Ltd. is a biopharmaceutical company that focuses on innovative drug research and development and provides comprehensive pharmaceutical industry chain services including CRO and CDMO.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Pharma Supply Chain, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Vcare Pharmatech Co., Ltd. Comparables
Compare Jiangsu Vcare Pharmatech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioDuro-Sundia | 74% | |
| Bayer AG | 73% | |
| Eli Lilly and Company | 73% | |
Jiangsu Vcare Pharmatech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 2, 2026 | ||||
| Series C Extension | Jan 22, 2025 | ||||
| Series C | Jan 2, 2024 | ||||
| Series B | Dec 26, 2022 | ||||
| Series A | May 6, 2022 | ||||
Series A | Jul 29, 2021 |
Jiangsu Vcare Pharmatech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongcheng Capital | Series B |
| DYEE Capital | Series C |
| SDIC Capital Co., Ltd. | Series C Extension, Series B, Series A |
| 南京市创新投资集团有限责任公司 | Series C, Series A |
| China Life Private Equity Investment | Series C |
| Yangtze River Industry Group | Series A, Series B |
| China Life Private Equity Investment Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
$29.4M round completed.
- Jan 22, 2025
$28M round with SDIC Capital Co., Ltd. participating.
Jiangsu Vcare Pharmatech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jiangsu Vcare Pharmatech Co., Ltd.'s valuation, stock price, and market status.